Insufficient scRNA-seq data for expression of TFIP11 at single-cell level.
Insufficient scRNA-seq data for expression of TFIP11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1253.75 | 1444 / 1445 | 100% | 17.46 | 183 / 183 |
skin | 100% | 1882.33 | 1809 / 1809 | 100% | 28.96 | 471 / 472 |
stomach | 100% | 1064.19 | 358 / 359 | 100% | 14.55 | 286 / 286 |
lung | 100% | 1289.38 | 576 / 578 | 100% | 18.54 | 1152 / 1155 |
breast | 100% | 1374.51 | 459 / 459 | 99% | 19.89 | 1109 / 1118 |
intestine | 100% | 1249.67 | 965 / 966 | 99% | 14.13 | 522 / 527 |
brain | 99% | 951.37 | 2611 / 2642 | 100% | 21.47 | 704 / 705 |
bladder | 100% | 1196.00 | 21 / 21 | 99% | 15.18 | 497 / 504 |
pancreas | 100% | 865.59 | 327 / 328 | 99% | 15.07 | 176 / 178 |
thymus | 100% | 1481.33 | 653 / 653 | 99% | 16.72 | 596 / 605 |
prostate | 100% | 1193.76 | 245 / 245 | 98% | 13.70 | 494 / 502 |
ovary | 100% | 1058.49 | 180 / 180 | 98% | 12.11 | 421 / 430 |
uterus | 100% | 1215.04 | 170 / 170 | 98% | 17.08 | 449 / 459 |
kidney | 100% | 1072.48 | 89 / 89 | 98% | 15.13 | 879 / 901 |
liver | 100% | 1084.89 | 226 / 226 | 95% | 14.37 | 386 / 406 |
adrenal gland | 100% | 1388.57 | 258 / 258 | 87% | 8.96 | 199 / 230 |
adipose | 100% | 1309.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1053.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 25.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.06 | 29 / 29 |
muscle | 100% | 2481.03 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1872.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.77 | 45 / 45 |
peripheral blood | 99% | 1891.30 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 879.11 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031848 | Biological process | protection from non-homologous end joining at telomere |
GO_0006396 | Biological process | RNA processing |
GO_2001033 | Biological process | negative regulation of double-strand break repair via nonhomologous end joining |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000390 | Biological process | spliceosomal complex disassembly |
GO_0031214 | Biological process | biomineral tissue development |
GO_1904876 | Biological process | negative regulation of DNA ligase activity |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0005730 | Cellular component | nucleolus |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0071008 | Cellular component | U2-type post-mRNA release spliceosomal complex |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TFIP11 |
Protein name | Tuftelin interacting protein 11 Tuftelin-interacting protein 11 Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) |
Synonyms | CTA-445C9.9-015 HSPC006 STIP |
Description | FUNCTION: Involved in pre-mRNA splicing, specifically in spliceosome disassembly during late-stage splicing events. Intron turnover seems to proceed through reactions in two lariat-intron associated complexes termed Intron Large (IL) and Intron Small (IS). In cooperation with DHX15 seems to mediate the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns. May play a role in the differentiation of ameloblasts and odontoblasts or in the forming of the enamel extracellular matrix. . FUNCTION: Involved in pre-mRNA splicing, specifically in spliceosome disassembly during late-stage splicing events. Intron turnover seems to proceed through reactions in two lariat-intron associated complexes termed Intron Large (IL) and Intron Small (IS). In cooperation with DHX15 seems to mediate the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns. May play a role in the differentiation of ameloblasts and odontoblasts or in the forming of the enamel extracellular matrix. . |
Accessions | ENST00000407690.6 [Q9UBB9-1] F6UKU9 ENST00000420242.5 F6UQ07 ENST00000455080.5 ENST00000440258.1 ENST00000407148.5 [Q9UBB9-1] ENST00000450493.1 F6XM96 H0Y4U8 ENST00000405938.5 [Q9UBB9-1] Q8N523 ENST00000418876.5 F6SQZ1 B1AHQ3 Q9UBB9 ENST00000407431.5 [Q9UBB9-1] ENST00000619735.4 [Q9UBB9-1] |